Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04035486 |
|---|---|
| Brief Title: | A Study of Osimertinib With or Without Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer (FLAURA2) (FLAURA2) |
| First Submitted : | June 27, 2019 |
| First Submitted that Met QC Criteria : | July 25, 2019 |
| First Posted : | July 29, 2019 |
| Last Update Submitted that Met QC Criteria : | February 12, 2024 |
| Last Update Posted : | February 14, 2024 |